Elspar and plasminogen decreased Patient Reports February 13, 2012

Elspar Side Effects Report #4561835-8
Elspar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 18 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, cerebrovascular accident, leukaemia recurrent, plasminogen decreased, subclavian vein thrombosis. Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.

Elspar Side Effects Report #4564794-7
Elspar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 18 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, cerebral infarction, cerebrovascular accident, leukaemia recurrent, plasminogen decreased, subclavian vein thrombosis, vascular occlusion. Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.

Elspar Side Effects Report #4562557-X
Elspar side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, blood fibrinogen decreased, cerebral thrombosis, coagulopathy, plasminogen decreased. Elspar dosage: unknown. Patient was hospitalized. Patient recovered.

Elspar Side Effects Report #4583204-7
Elspar side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, blood fibrinogen decreased, cerebral thrombosis, coagulopathy, plasminogen decreased. Elspar dosage: unknown. Patient was hospitalized. Patient recovered.


Elspar Side Effects Report #4647538-X
Elspar side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, back pain , blood fibrinogen decreased, cerebral artery embolism, hyperglycaemia, plasminogen decreased. Elspar dosage: unknown. During the same period patient was treated with VINDESINE, ACLARUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE, DAUNORUBICIN, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.